S. B. Prusiner, Novel proteinaceous infectious particles cause scrapie, Science, vol.216, issue.4542, pp.136-180, 1982.

G. G. Kovacs and H. Budka, Molecular pathology of human prion diseases, Int J Mol Sci, vol.10, issue.3, pp.976-99, 2009.

B. W. Caughey, A. Dong, K. S. Bhat, D. Ernst, S. F. Hayes et al., Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy, Biochemistry, vol.30, issue.31, pp.7672-80, 1991.

K. M. Pan, M. Baldwin, J. Nguyen, M. Gasset, A. Serban et al., Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins, Proc Natl Acad Sci, vol.90, issue.23, pp.10962-10968, 1993.

P. Gambetti, Z. Dong, J. Yuan, X. Xiao, M. Zheng et al., A novel human disease with abnormal prion protein sensitive to protease, Ann Neurol, vol.63, issue.6, pp.697-708, 2008.

M. W. Head, R. Knight, M. Zeidler, H. Yull, A. Barlow et al., A case of protease sensitive prionopathy in a patient in the UK, Neuropathol Appl Neurobiol, vol.35, issue.6, pp.628-660, 2009.

C. Jansen, M. W. Head, W. A. Van-gool, F. Baas, H. Yull et al., The first case of protease-sensitive prionopathy (PSPr) in The Netherlands: a patient with an unusual GSS-like clinical phenotype, J Neurol Neurosurg Psychiatry, vol.81, issue.9, pp.1052-1057, 2010.

W. Q. Zou, G. Puoti, X. Xiao, J. Yuan, L. Qing et al., Variably proteasesensitive prionopathy: a new sporadic disease of the prion protein, Ann Neurol, vol.68, issue.2, pp.162-72, 2010.

J. Safar, H. Wille, V. Itri, D. Groth, H. Serban et al., Eight prion strains have PrP(Sc) molecules with different conformations, Nat Med, vol.4, issue.10, pp.1157-65, 1998.

S. Tzaban, G. Friedlander, O. Schonberger, L. Horonchik, Y. Yedidia et al., Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes, Biochemistry, vol.41, issue.42, pp.12868-75, 2002.

J. G. Safar, M. D. Geschwind, C. Deering, S. Didorenko, M. Sattavat et al., Diagnosis of human prion disease, Proc Natl Acad Sci U S A, vol.102, issue.9, pp.3501-3507, 2005.

M. A. Pastrana, G. Sajnani, B. Onisko, J. Castilla, R. Morales et al., Isolation and characterization of a proteinase K-sensitive PrPSc fraction, Biochemistry, vol.45, issue.51, pp.15710-15717, 2006.

B. Caughey and P. T. Lansbury, Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders, Annu Rev Neurosci, vol.26, pp.267-98, 2003.

J. R. Silveira, G. J. Raymond, A. G. Hughson, R. E. Race, V. L. Sim et al., The most infectious prion protein particles, Nature, vol.437, issue.7056, pp.257-61, 2005.

S. Simoneau, H. Rezaei, N. Sales, G. Kaiser-schulz, M. Lefebvre-roque et al., In vitro and in vivo neurotoxicity of prion protein oligomers, PLoS Pathog, vol.3, issue.8, p.125, 2007.

A. Ayrolles-torro, T. Imberdis, J. Torrent, K. Toupet, I. V. Baskakov et al., Oligomeric-induced activity by thienyl pyrimidine compounds traps prion infectivity, J Neurosci, vol.31, issue.42, pp.14882-92, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00635922

T. Imberdis, A. Ayrolles-torro, J. M. Verdier, and V. Perrier, Thienyl pyrimidine derivatives with PrP(Sc) oligomer-inducing activity are a promising tool to study prions, Curr Top Med Chem, vol.13, pp.2477-83, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01104775

R. Duarte, V. Perrier, and M. Robitzer, Improved synthesis of a quaterthiophenetriazine-diamine derivative, a promising molecule to study pathogenic prion proteins, Tetrahedron Lett, vol.56, issue.2, pp.368-73, 2015.

N. Makarava and I. V. Baskakov, The same primary structure of the prion protein yields two distinct self-propagating states, J Biol Chem, vol.283, issue.23, pp.15988-96, 2008.

V. G. Ostapchenko, M. R. Sawaya, N. Makarava, R. Savtchenko, K. P. Nilsson et al., Two amyloid States of the prion protein display significantly different folding patterns, J Mol Biol, vol.400, issue.4, pp.908-929, 2010.

H. Ludewigs, C. Zuber, K. Vana, D. Nikles, I. Zerr et al., Therapeutic approaches for prion disorders, Expert Rev Anti Infect Ther, vol.5, issue.4, pp.613-643, 2007.

J. Wagner, S. Ryazanov, A. Leonov, J. Levin, S. Shi et al., Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease, Acta Neuropathol, vol.125, issue.6, pp.795-813, 2013.

J. Bieschke, T. Wiglenda, R. P. Friedrich, A. Boeddrich, F. Schiele et al., Small-molecule conversion of toxic oligomers to nontoxic ?-sheet-rich amyloid fibrils nature chemical biology, Nat Chem Biol, vol.8, pp.93-101, 2012.

L. Cui, Y. Zhang, H. Cao, Y. Wang, T. Teng et al., Ferulic acid inhibits the transition of amyloid-beta42 monomers to oligomers but accelerates the transition from oligomers to fibrils, J Alzheimers Dis, vol.37, issue.1, pp.19-28, 2013.

T. Klingstedt, H. Shirani, K. O. Aslund, N. J. Cairns, C. J. Sigurdson et al., The structural basis for optimal performance of oligothiophene-based fluorescent amyloid ligands: conformational flexibility is essential for spectral assignment of a diversity of protein aggregates, Chemistry, vol.19, issue.31, pp.10179-92, 2013.

R. A. Simon, H. Shirani, K. O. Aslund, M. Back, V. Haroutunian et al., Pentameric thiophene-based ligands that spectrally discriminate amyloid-beta and tau aggregates display distinct solvatochromism and viscosity-induced spectral shifts, Chemistry, vol.20, issue.39, pp.12537-12580, 2014.

J. D. Wadsworth, S. Joiner, A. F. Hill, T. A. Campbell, M. Desbruslais et al., Tissue distribution of protease resistant prion protein in variant CreutzfeldtJakob disease using a highly sensitive immunoblotting assay, Lancet, vol.358, issue.9277, pp.171-80, 2001.

U. S. Herrmann, A. K. Schutz, H. Shirani, D. Huang, D. Saban et al., Structure-based drug design identifies polythiophenes as antiprion compounds, Sci Transl Med, vol.7, issue.299, pp.299-123, 2015.

N. Nishida, D. A. Harris, D. Vilette, H. Laude, Y. Frobert et al., Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein, J Virol, vol.74, issue.1, pp.320-325, 2000.

V. Perrier, J. Solassol, C. Crozet, Y. Frobert, C. Mourton-gilles et al., Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPC degradation, J Neurochem, vol.89, issue.2, pp.454-63, 2004.
URL : https://hal.archives-ouvertes.fr/inserm-00143226

H. Rezaei, D. Marc, Y. Choiset, M. Takahashi, H. B. Hoa et al., High yield purification and physico-chemical properties of full-length recombinant allelic variants of sheep prion protein linked to scrapie susceptibility, Eur J Biochem, vol.267, issue.10, pp.2833-2842, 2000.

O. V. Bocharova, L. Breydo, A. S. Parfenov, V. V. Salnikov, and I. V. Baskakov, In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc), J Mol Biol, vol.346, issue.2, pp.645-59, 2005.

D. El-moustaine, V. Perrier, L. Smeller, R. Lange, and J. Torrent, Full-length prion protein aggregates to amyloid fibrils and spherical particles by distinct pathways, FEBS J, vol.275, issue.9, pp.2021-2052, 2008.

G. Paxinos and K. B. Franklin, Paxinos and Franklin's the mouse brain in stereotaxic coordinates, 2012.

G. A. Carlson, D. T. Kingsbury, P. A. Goodman, S. Coleman, S. T. Marshall et al., Linkage of prion protein and scrapie incubation time genes, Cell, vol.46, issue.4, pp.503-514, 1986.

M. Scott, D. Foster, C. Mirenda, D. Serban, F. Coufal et al., Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques, Cell, vol.59, issue.5, pp.847-57, 1989.

O. Andreoletti and . Prp, Techniques in prion research, Birhauser Basel, pp.82-96, 2004.

K. Toupet, V. Compan, C. Crozet, C. Mourton-gilles, N. Mestre-frances et al., Effective gene therapy in a mouse model of prion diseases, PLoS One, vol.3, issue.7, p.2773, 2008.
URL : https://hal.archives-ouvertes.fr/hal-01667611